Showing results (581-590 of 9,900) with videos related to
Sort By:
Pageof 990
Bone Marrow Transplantation|May 1, 1991
Cardiac arrest after autologous marrow infusionA P Rapoport, J M Rowe, C H Packman, et al.Bone Marrow Transplantation|August 11, 2010
High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AMLA O'Meara, T Pabst, D Heim, et al.Bone Marrow Transplantation|August 11, 2010
Early detection of relapse in patients with myelodysplastic syndrome after allo-SCTM Tobiasson, R Olsson, E Hellström-Lindberg, et al.Bone Marrow Transplantation|August 11, 2010
Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCTS Gerull, C Arber, C Bucher, et al.Bone Marrow Transplantation|August 11, 2010
Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCTB L Laskin, J Goebel, S M Davies, et al.Bone Marrow Transplantation|August 17, 2010
Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicityJ Pidala, J Kim, C Anasetti, et al.Bone Marrow Transplantation|August 3, 2010
GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcomeA Alsultan, R H Giller, D Gao, et al.Bone Marrow Transplantation|June 10, 2010
Impact of the European clinical trials directive on prospective academic clinical trials associated with BMTL J Frewer, D Coles, I A van der Lans, et al.Bone Marrow Transplantation|June 10, 2010
Role of allo-SCT for CML in 2010N Venepalli, K Rezvani, S Mielke, et al.Bone Marrow Transplantation|June 22, 2010
High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myelomaH W Auner, L Mazzarella, L Cook, et al.Pageof 990